We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters

- Hemostasis | Oral Contraceptive
- Completed

Study Title: A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women

Teva Identifier: DSG-HSP-201

ClinicalTrials.gov Identifier: NCT01388491

Study Status: Completed

Trial Condition(s): Hemostasis | Oral Contraceptive

Interventions: Drug: desogestrel/ethinyl estradiol and ethinyl estradiol | Drug: desogestrel/ethinyl estradiol

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

female icon for clinical trials

Key Participation Requirements

Gender: Female

Age Range: 18 Years to 40 Years

Trial Duration: 10/01/2011 - 09/01/2012

Phase: Phase 2

Study Type

Interventional